3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
7
Prostatic Neoplasms
6
Hematopoietic and Lymphatic System Neoplasm
6
Hematologic Neoplasms
6
Colorectal Neoplasms
5
Breast Neoplasms
5
Anatomic Stage I Breast Cancer AJCC v8
5
Pancreatic Neoplasms
3
Neoplasms
3
Malignant Solid Neoplasm
3
Leukemia, Myeloid, Acute
3
Urinary Bladder Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Ovarian Neoplasms
2
Mouth Neoplasms
2
Melanoma
2
Head and Neck Carcinoma
2
Glioma
2
Carcinoma, Renal Cell
2
Carcinoma
2
COVID-19
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Urologic Diseases
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Tonsillar Neoplasms
1
Tongue Neoplasms
1
Teratoma
1
Interventions
Magnetic Resonance Spectroscopy
6
Biopsy
6
X-Rays
5
Specimen Handling
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
4
Cisplatin
3
Carboplatin
3
tazemetostat
2
selpercatinib
2
larotrectinib
2
erdafitinib
2
entrectinib
2
ensartinib
2
cabozantinib
2
Topotecan
2
Temozolomide
2
Surveys and Questionnaires
2
Radiation
2
LY3023414
2
Gemcitabine
2
Etoposide
2
Cyclophosphamide
2
ulixertinib
1
tipifarnib
1
pegfilgrastim
1
palbociclib
1
olaparib
1
niraparib
1
mirdametinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Central Nervous System Neoplasms
×
Practice Guidelines as Topic
×
90 days
×
Clear all
No trials found.